Co-founder and CEO, @iambic_ai. Formerly: Professor of Chemistry, @Caltech. Views my own.
San Diego, CA
Joined September 2017
- Tweets1.2K
- Following611
- Followers3.4K
- Likes3.6K
Many thanks to BIOS for the great discussion on the exciting progress and future of the @iambic_ai team!
BIOS Builders 🧱 w/ Tom Miller - Co-Founder & CEO @ Iambic Therapeutics
Tune into our latest episode featuring @tfmiller3 discussing the genesis and future vision of @iambic_ai
See Below:
buff.ly/3FffTNb
Exciting day. So long Entos, hello Iambic. Congratulations to this extraordinary team.
Entos is now Iambic Therapeutics! We are excited to announce that Iambic has closed a $100 Million Series B to continue work on advancing AI-discovered therapeutics into clinical development as we enter a collaboration with @NVIDIAAI.
Full press release: iambic.ai/post/series-b
Thomas Miller retweeted
We are thrilled to announce that legendary biotech executive William Rastetter has joined the Entos Board, as well as the establishment of a world-class Clinical Advisory Board with founding members Dr Alex Adjei, Dr Maria Koehler, and Dr Kwok-Kin Wong!
entos.ai/blog/entos-recruits…
Thomas Miller retweeted
Join Entos co-founder and CEO @tfmiller3 on March 20 at #GTC23 to learn about our demonstration of generative AI-driven drug discovery. #healthcare #NVIDIAInception
nvidia.com/gtc/session-catal…
Thomas Miller retweeted
Thank you @TheOfficialACM for recognizing me as an ACM Fellow! This honor belongs to my team and collaborators. Every day I am energized and inspired to work with them. Also thankful to my mentors and my family for supporting me all this way!
💐Meet the 2022 ACM Fellows! 57 of the ACM members have been selected for their wide-ranging and fundamental contributions in the #computing field. Please join us in congratulating these new inductees!
Learn more about their achievements here: bit.ly/3CXulZz
#ACMFellows
Thomas Miller retweeted
Congratulations to our Head of Business Development, Mary Anderson for being named among the top 25 healthcare technology leaders of San Diego by The Healthcare Technology Report. We could not be more pleased about her well-deserved recognition!
entos.ai/blog/entos-head-of-…
Thomas Miller retweeted
#Diffusion models are effective for protein-ligand structure prediction with equivariant transformers. Our method NeuralPLexer accurately inpaints binding site while using #alphafold doesn't. @ZhuoranQ @wn8_nie @ArashVahdat @tfmiller3
Dynamic-Backbone Protein-Ligand Structure Prediction with Multiscale Generative Diffusion Models
abs: arxiv.org/abs/2209.15171
We couldn't be more excited about this wonderful addition to the @EntosAI team.
We are incredibly excited to announce the appointment of veteran biotech exec Chao Zhang as Entos Chief Scientific Officer. Chao's recruitment heralds the transition of Entos from a discovery-stage to a clinical-stage AI-driven biotech.
entos.ai/blog/chao-zhang-joi…
Thomas Miller retweeted
We’re honored to see Entos recognized in the @Forbes #AI50 list for AI companies shaping the future 🚀
forbes.com/lists/ai50
Come join our incredible team of #DrugDiscovery and #MachineLearning scientists! We're hiring 👉 entos.ai/careers
Thomas Miller retweeted
This is a day that belongs to @clemonslab. Thanks to everyone who has mentored me and worked hard to support my crazy ideas.
Congratulations to Professor Bil Clemons (@profbilc) and Professor Linda Hsieh-Wilson (@Lhsiehwilson) on being elected to the National Academy of Sciences! 🎉
Thomas Miller retweeted
Our collaborative work with @zhejliu and @TjianDarzacq is now published in Nat Genet. Huge thanks to @549nm and @Yifeng_QI for their years of effort!
nature.com/articles/s41588-0…
Fantastic day at @TAMUChemistry! It's always exciting to visit my home institution, meeting old friends and awesome new faculty. And the recognition from the @TAMUScience is a huge honor. Thank you!
This Post is from an account that no longer exists. Learn more
Thomas Miller retweeted
Read about our labmate and friend @RomanKorol7's thoughts on the situation in his native Ukraine and what he's doing to help. More info on how to contribute to relief efforts: its.caltech.edu/~rkorol/acti…
Caltech graduate student Roman Korol, a Ukrainian citizen, has found himself hopelessly preoccupied by the war in his homeland. He has found support from the Caltech community in his recent effort to collect humanitarian supplies for his compatriots: caltech.edu/about/news/organ…
Looking forward to joining this great lineup!
Tune in to Tom Miller's talk at The 6th Annual Frontiers in Therapeutics and Diagnostics (FTD) Forum to learn about how we're applying #AI to #drugdiscovery at Entos. Happening this Saturday at 2:50pm PST!
Full program and zoom link can be found here: sabpa.org/member/event.php?i…
Thomas Miller retweeted
We’re hiring a Senior Software Engineer to advance our core mission of accelerating small molecule drug discovery at Entos!
The candidate will play a leadership role in identifying new software technologies, ensuring ecosystem robustness, and driving development best practices.
Thomas Miller retweeted
We are thrilled to have Nick Saccomano joining the Entos Scientific Advisory Board. Nick brings 35 years of R&D experience across a broad spectrum of therapeutic areas and modalities and his expertise will help drive the drug discovery happening at Entos!
entos.ai/blog/entos-appoints…
Thomas Miller retweeted
A short summary of my #AI #research #Highlights2021 Grateful to have an amazing team of students and researchers at @Caltech and @nvidia #HappyNewYear anima-ai.org/2021/12/30/top-…
Thomas Miller retweeted
We are saddened by the passing of Naren Gupta, one of Entos' earliest investors and advocates. We are forever grateful for his guidance and friendship and we extend our heartfelt sympathies to Naren’s family and friends during this time.
entos.ai/blog/entos-mourns-t…